CURE - Oncology & Cancer News for Patients & Caregivers
CURE - Oncology & Cancer News for Patients & Caregivers
Spotlight
BlogsClinical Trial CornerCURE's 20th Anniversary CelebrationPodcastsPublicationsRecipesVideos
Cancer Type
View MoreBladderBreastCLLKidneyLungMCLOvarianProstateSkin
About CURE
Press ReleasesShare Your StoryWrite for CURE
News
Cancer Horizons
All News
Blogs
Caregiving
Diet and Exercise
Financial
Psychosocial
Recipes
Sexual Health
Side Effect
Sponsored
Survivorship
Videos
All Videos
CURE Connections
CURE Expert Connections
CURE Speaking Out
CURE TV
On Demand: Award Programs
On Demand: Patient Summits
On Demand: Webinars
Conferences
Conference Coverage
Conference Listing
Events
CURE Adventures
Award Programs
Educated Patient Summits
Educated Patient Webinars
Resources
Advocacy Groups
Art Gallery
Clinical Trial Corner
CURE Ambassador Program
Educated Patient Research Updates
Interactive Tools
Journey
Partners
Podcasts
Publications
Share Your Story
Subscribe
CURE Magazine
HEAL Magazine
Sign Up for eNews
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information

© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Spotlight
  • Blogs
  • Clinical Trial Corner
  • CURE's 20th Anniversary Celebration
  • Podcasts
  • Publications
  • Recipes
  • Videos
Cancer TypeSee All >
  • Bladder
  • Breast
  • CLL
  • Kidney
  • Lung
  • MCL
  • Ovarian
  • Prostate
  • Skin
About CURE
  • Press Releases
  • Share Your Story
  • Write for CURE
  • About
  • Advertise / Support
  • Contact
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

Role of Tivozanib in Renal Cell Carcinoma (RCC)

Thomas Hutson, DO, PharmD discusses the role of tivozanib in the treatment landscape for patients with renal cell carcinoma.

EP. 1: Treatment Options for Patients with Renal Cell Carcinoma (RCC)

June 15th 2022

An overview of the treatment options available for patients with renal cell carcinoma (RCC).

EP. 2: Clinical Implications of the TIVO-3 Trial

June 15th 2022

Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.

EP. 3: Tivozanib: Adverse Event Profile and How Toxicities are Managed

June 22nd 2022

Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.

EP. 4: Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

June 22nd 2022

Dr Thomas Hutson shares his experience with tivozanib in his practice and ways to counsel patients regarding treatment options in the third-line setting.

Latest News

FDA Grants Orphan Drug Designation to Novel CAR-T Cell Therapy to Treat Waldenstrom Macroglobulinemia, a Rare Type of Cancer

New Resource ‘Empowers’ Patients With Breast Cancer That Has Spread to the Brain With Much Needed Information

Cancer Boosted My Empathy, But Anger Is Starting to Rear Its Head

FDA Approves Breyanzi for Previously Treated Large B-Cell Lymphoma

View More Latest News